Trust the experts who advanced 500+ oncology projects in 2021.

With more than 80% of novel compounds to treat cancer coming from emerging biopharma, small biotechs are clearly betting big on oncology. But to achieve regulatory and scientific success, these drug programs must first clear some serious hurdles: - Scientific: How will you develop a dose optimization strategy in light of the FDA’s Project Optimus? - Regulatory: How do you navigate the regulatory requirements of various global health authorities? - Commercial: How will you justify your product’s value to payers and other relevant stakeholders? We can help. With deep experience in model-informed oncology drug development, dosing and regulatory strategy and submission, Certara has helped to advance hundreds of oncology programs. Read below for examples of how we’re helping our oncology clients achieve scientific, regulatory, and commercial success!

Oncology Resources

Certara Project Optimus Oncology Bottom

Are you Ready for Project Optimus?

How can we help?

Back to top